SWISS-PROT & PROSITE IMPORTANT ANNOUNCEMENT It became obvious in the last years that the tremendous increase in data flow has created a requirement for resources which cannot be addressed in full by public funding. This is causing databases to fall behind the research. We believe that the only solution to the resource shortfall is to ask commercial users to participate by paying a license fee. No fee will be charged to academic users, nor will any restriction be imposed on their use or reuse of the data. both SWISS-PROT and PROSITE are concerned by these changes while this is not the case of ENZYME. A document fully describing what will be the impact of this change for SWISS-PROT is available with the SWISS-PROT distribution files on FTP (SP_98.TXT). You can also access the document as well as other relevant ones from: http://www.expasy.ch/announce/ http://www.ebi.ac.uk/news.html If you do not have the time to read this document, the most important take-home message is that these changes should not have any impact on the way SWISS-PROT or PROSITE are accessed or redistributed. Academic users will not be affected by these changes. Industrial end-users will also not directly be affected as long as their employer pays the license fee. The same holds true for bioinformatics companies. Academic software or database developers as well as providers of database distribution services will be only minimally affected by these changes. We hope to be able to ensure their long-term financial survival. We sincerely hope and believe that in the next two years the only change that will matter will be the increase in scope and timeliness of the databases. Finally, it should be noted that release 36 of SWISS-PROT and release 15 of PROSITE are not concerned by these changes. There are no restrictions on their use and their distribution.